Ozempic predecessor may slow Parkinson’s progression, new study shows
By Erica Carbajal for Becker’s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made
Read MoreBy Erica Carbajal for Becker’s Hospital Review on April 4, 2024 A small study has found lixisenatide, a GLP-1 made
Read More(Source – news.va.gov) VA makes another historic move to provide coverage for Parkinson’s disease as a neurobehavioral condition under its
Read More